Varicella: Previously healthy children sometimes develop complications;Waterpokken: Soms complicaties bij voorheen gezonde kinderen

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 48, 2006, Pages 2625-2629

  Merelle M E ^a   Visser, L F A ^a   Bokma, J A ^a   De Melker, H E ^b   De Winter, J P ^a  

^a Department of Orthopaedic Surgery   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; BACTERIAL SKIN DISEASE; CEREBELLAR ATAXIA; CHICKENPOX; CHILD; HOSPITAL ADMISSION; HUMAN; NEUROLOGIC DISEASE; PNEUMONIA; SOFT TISSUE INFECTION; VACCINATION;

CEREBELLAR ATAXIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD, PRESCHOOL; HEALTH POLICY; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; NETHERLANDS; PLEUROPNEUMONIA; SKIN DISEASES, BACTERIAL;

EID: 33845295762     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. English R. Varicella. Pediatr Rev. 2003;24:372-9.
2. Gnann jr JW. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186(Suppl 1):S91-8.
3. Rentier B, Gershon AA. Consensus: varicella vaccination of healthy children - a challenge for Europe. European Working Group on Varicella. Pediatr Infect Dis J. 2004;23:379-89.
4. Melker H de, Berbers G, Hahné S, Rümke HC, Hof S van den, Wit A de, et al. The epidemiology of varicella and herpes zoster in the Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006;24:3946-52.
5. Thiry N, Beutels P, Damme P van, Doorslaer E van. Economic evaluations of varicella vaccination programmes: a review of the literature. Pharmacoeconomics. 2003;21:13-38.
6. Ziebold C, Kries R von, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001;108:E79.
7. Tseng HW, Liu CC, Wang SM, Yang YJ, Huang YS. Complications of varicella in children: emphasis on skin and central nervous system disorders. J Microbiol Immunol Infect. 2000;33:248-52.
8. Geelen SPM, Graeff-Meeder ER de. Invasieve streptokokkeninfectie als complicatie van waterpokken. Ned Tijdschr Geneeskd. 1998;142:1113-6.
9. Kuitwaard K, Naafs D, Haasnoot K, Houten R ter. Een jongen van 15 maanden met een herseninfarct. Tijdschr Kindergeneeskd. 2005;73:184-7.
10. Vazquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, et al. Effectiveness over time of varicella vaccine. JAMA. 2004;291:851-5.
11. Marin M, Nguyen HQ, Keen J, Jumaan AO, Mellen PM, Hayes EB, et al. Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003. Pediatrics. 2005;115:900-5.
12. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis. 2005;191:2002-7.
13. Gershon A, Takahashi M, Seward J. Varicella vaccine. In: Plotkin S, Orenstein W, editors. Vaccins. 4th ed. Philadelphia: Saunders; 2004. p. 783-823.
14. Grose C. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005. J Clin Virol. 2005;33:89-95.
15. Nguyen HQ, Jumaan AO, Seward JE. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352:450-8.
16. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294;797-802.
17. Sheffer R, Segal D, Rahamani S, Dalal I, Linhart Y, Stein M, et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J. 2005;24:434-7.
18. Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, et al. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics. 1994;94(4 Pt 1):524-6.
19. Bovenkamp-Meijer KJT van de, Rümke HC. Twijfels over kindervaccinaties: betere voorlichting zal het draagvlak versterken. Med Contact. 2005;60:18-21.
20. Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Study Group for Varivax. Pediatr Infect Dis J. 2004;23:132-7.
21. Shinefield H, Black S, Williams WR, Marchant C, Reisinger K, Stewart T, et al. Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Dose Selection Study Group for Proquad. Pediatr Infect Dis J. 2005;24:670-5.
22. Shinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J. 2005;24:665-9.